# An Open-Label PET/CT Imaging Study to Evaluate Brain Serotonin Transporter (SERT) Occupancy Following Single-Dose Administration of LG-0317 Tablets in Healthy Participants

> **NCT07708428** · PHASE1 · NOT_YET_RECRUITING · sponsor: **LinGang Laboratory** · enrollment: 12 (estimated)

## Conditions studied

- Healthy Volunteers (HV)

## Interventions

- **DRUG:** Cohort 1: LG-0317 20 mg
- **DRUG:** Cohort 1: LG-0317 40 mg
- **DRUG:** Cohort 1: LG-0317 80 mg

## Key facts

- **NCT ID:** NCT07708428
- **Lead sponsor:** LinGang Laboratory
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-24
- **Primary completion:** 2026-09-30
- **Final completion:** 2027-02-02
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07708428

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07708428, "An Open-Label PET/CT Imaging Study to Evaluate Brain Serotonin Transporter (SERT) Occupancy Following Single-Dose Administration of LG-0317 Tablets in Healthy Participants". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07708428. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*